These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2714728)

  • 1. Effect of renal failure on the pharmacokinetics of ethyl loflazepate (Victan) in man.
    Ba BB; Iliadis A; Durand A; Berger Y; Necciari J; Cano JP
    Fundam Clin Pharmacol; 1989; 3(1):11-7. PubMed ID: 2714728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic modeling of ethyl loflazepate (Victan) and its main active metabolites.
    Ba BB; Iliadis A; Cano JP
    Ann Biomed Eng; 1989; 17(6):633-46. PubMed ID: 2574017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethyl loflazepate: a prodrug from the benzodiazepine series designed to dissociate anxiolytic and sedative activities.
    Chambon JP; Perio A; Demarne H; Hallot A; Dantzer R; Roncucci R; Bizière K
    Arzneimittelforschung; 1985; 35(10):1573-7. PubMed ID: 2866771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of ethyl loflazepate in the rat, the dog, the baboon and in man.
    Davi H; Guyonnet J; Sales Y; Cautreels W
    Arzneimittelforschung; 1985; 35(7):1061-5. PubMed ID: 2864933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approach in bioavailability study of two formulations of ethyl loflazepate.
    Ba BB; Iliadis A; Durand A; Berger Y; Cano JP
    Arzneimittelforschung; 1988 Oct; 38(10):1486-9. PubMed ID: 2904268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The respiratory effects of oral ethyl loflazepate in volunteers.
    Fazackerley EJ; Randall NP; Pleuvry BJ; Bradbrook I; Mawer GE
    Br J Clin Pharmacol; 1987 Feb; 23(2):183-7. PubMed ID: 2881572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of circulating ethyl loflazepate metabolites in the baboon by radio-high-performance liquid chromatography with injection of crude plasma samples: comparison with solvent extraction and thin-layer chromatography.
    Davi H; Guyonnet J; Necciari J; Cautreels W
    J Chromatogr; 1985 Jul; 342(1):159-65. PubMed ID: 2864352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavioral effects of ethyl loflazepate and its metabolites].
    Ueki S; Watanabe S; Yamamoto T; Shibata S; Shibata K; Ohta H; Ikeda K; Kiyota Y; Sato Y
    Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):395-409. PubMed ID: 6142848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the metabolites of ethyl loflazepate by gas chromatography with electron-capture detection.
    Cano JP; Sumirtapura YC; Cautreels W; Sales Y
    J Chromatogr; 1981 Dec; 226(2):413-22. PubMed ID: 6119320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of the two major metabolites of ethyl loflazepate (CM6912) in dogs and humans. Simulation by a digital computer].
    Ito M; Aizawa K; Komiya I; Miyagi K; Fujita M; Umemura K
    Yakugaku Zasshi; 1986 Aug; 106(8):703-8. PubMed ID: 3806367
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative analysis of CM 6912 (ethyl loflazepate) and its metabolites in plasma and urine by chemical ionization gas chromatography mass spectrometry. Application to pharmacokinetic studies in man.
    Cautreels W; Jeanniot JP
    Biomed Mass Spectrom; 1980 Nov; 7(11-12):565-71. PubMed ID: 6112027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a new benzodiazepine derivative, ethyl loflazepate (CM6912), on the arousal level of normal humans assessed by the averaged photopalpebral reflex.
    Tanaka M; Mizuki Y; Isozaki H; Inanaga K
    Clin Neuropharmacol; 1985; 8(3):271-9. PubMed ID: 4042078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinical study of a new benzodiazepine anxiolytic agent, ethyl loflazepate, in dental practice].
    Poggioli J
    Rev Odontostomatol (Paris); 1982 Dec; 11(6):469-70. PubMed ID: 6131525
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of ethyl loflazepate on age-dependent epileptic encephalopathy].
    Ohira T; Azuma A; Matsuda I
    No To Hattatsu; 1993 Mar; 25(2):180-3. PubMed ID: 8461168
    [No Abstract]   [Full Text] [Related]  

  • 15. Stability study of ethyl loflazepate in bulk drug, solution and dosage form by liquid chromatography.
    Dabas PC; Ergüven H; Vescina MC; Carducci CN
    J Pharm Biomed Anal; 1992; 10(2-3):241-4. PubMed ID: 1356448
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of impaired renal function on the plasma concentration and urinary excretion of metoprolol metabolites.
    Hoffmann KJ; Regårdh CG; Aurell M; Ervik M; Jordö L
    Clin Pharmacokinet; 1980; 5(2):181-91. PubMed ID: 7363533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man.
    Houin G; Brunner F; Nebout T; Cherfaoui M; Lagrue G; Tillement JP
    Br J Clin Pharmacol; 1983 Sep; 16(3):245-52. PubMed ID: 6626415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of a single oral dose of clobazam in patients with liver disease.
    Monjanel-Mouterde S; Antoni M; Bun H; Botta-Frindlund D; Gauthier A; Durand A; Cano JP
    Pharmacol Toxicol; 1994 Jun; 74(6):345-50. PubMed ID: 7937568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of after-dinner administration on the pharmacokinetics of oral flunitrazepam and loprazolam.
    Bareggi SR; Pirola R; Truci G; Leva S; Smirne S
    J Clin Pharmacol; 1988 Apr; 28(4):371-5. PubMed ID: 3392235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
    Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B
    Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.